Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Genscript Biotech Corp, a leading life sciences service provider and drug developer, has raised HK$2.39bn ($304m) after upsizing a follow-on offering, according to a source close to the deal. -
Bayer, the German life sciences company, this week unveiled the terms for a €6bn rights issue, after its acquisition of Monsanto, the US agrochemical and biotech company, cleared its final regulatory hurdles last week.
-
China Merchants Securities’ head of equity syndicate in Hong Kong has taken up a new job in the capital markets team at Fidelity International.
-
Del Monte Philippines has kicked off bookbuilding for an up to Ps17.6bn ($334.5m) IPO after winning approval from the country's stock exchange on Wednesday.
-
Hong Kong-listed Enerchina Holdings has mooted a HK$1.3bn ($165.7m) cash call as it looks to boost its financial services business and repay debt.
-
HSBC has wooed two bankers from rival bulge bracket firms to join its equity capital markets desk as it beefs up its equities franchise in Asia, said sources close to the moves.
